日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies

一项针对单核细胞/巨噬细胞的组蛋白去乙酰化酶抑制剂 tefinostat 的 I 期首次人体试验,用于治疗晚期血液系统恶性肿瘤患者

Gert J Ossenkoppele, Bob Lowenberg, Pierre Zachee, Norbert Vey, Dimitri Breems, Arjan A Van de Loosdrecht, Alan H Davidson, Graham Wells, Lindsey Needham, Lindsay Bawden, Martin Toal, Leon Hooftman, Phillip M Debnam

AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion

AML1-ETO 融合蛋白上调人类 CD34+ 细胞中的 TRKA mRNA 表达,从而实现神经生长因子诱导的扩增

James C Mulloy, Vladimir Jankovic, Mark Wunderlich, Ruud Delwel, Jorg Cammenga, Ondrej Krejci, Hui Zhao, Peter J M Valk, Bob Lowenberg, Stephen D Nimer